We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 21-40 of 6,010 results
  1. A real-world comparison of tisagenlecleucel and axicabtagene ciloleucel CAR T cells in relapsed or refractory diffuse large B cell lymphoma

    Axicabtagene ciloleucel (axi-cel) and tisagenlecleucel (tisa-cel) have both demonstrated impressive clinical activity in relapsed/refractory (R/R)...

    Emmanuel Bachy, Steven Le Gouill, ... Franck Morschhauser in Nature Medicine
    Article Open access 22 September 2022
  2. Associations of circulating advanced glycation end products and their soluble receptors with cancer risk: A systematic review and meta-analysis of observational studies

    Advanced glycation end products (AGE) in complex with their receptors (RAGE) cause a chronic inflammatory state in the body, which is the major...

    Fatemeh Hajizadeh-Sharafabad, Sara Shojaei-Zarghani, ... Mohammad Reza Pashaei in Glycoconjugate Journal
    Article 01 February 2024
  3. Outcomes of first therapy after CD19-CAR-T treatment failure in large B-cell lymphoma

    Persistence or recurrence of large B-cell lymphoma after CD19-CAR-T is common, yet data guiding management are limited. We describe outcomes and...

    Ana Alarcon Tomas, Joshua A. Fein, ... Roni Shouval in Leukemia
    Article 05 November 2022
  4. A phase 2 study of axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma in Japan: 1-year follow-up and biomarker analysis

    Axicabtagene ciloleucel (axi-cel) is an autologous, CD19-targeting chimeric antigen receptor T‑cell therapy. We recently reported the 3-month...

    Koji Kato, Nobuharu Fujii, ... Kiyohiko Hatake in International Journal of Hematology
    Article 18 November 2022
  5. Shape correspondence for cel animation based on a shape association graph and spectral matching

    We present an effective spectral matching method based on a shape association graph for finding region correspondences between two cel animation...

    Shaolong Liu, **ngce Wang, ... Hock Soon Seah in Computational Visual Media
    Article Open access 29 April 2023
  6. Reducing and controlling metabolic active tumor volume prior to CAR T-cell infusion can improve survival outcomes in patients with large B-cell lymphoma

    Bridging therapy before CD19-directed chimeric antigen receptor (CAR) T-cell infusion is frequently applied in patients with relapsed or refractory...

    Kylie Keijzer, Janneke W. de Boer, ... Anne G. H. Niezink in Blood Cancer Journal
    Article Open access 07 March 2024
  7. Engineered T Cells: CAR T Cell Therapy and Beyond

    Purpose of Review

    This article reviews the current data and future directions of engineered T cell therapies in non-Hodgkin lymphomas.

    ...
    P. Connor Johnson, Jeremy S. Abramson in Current Oncology Reports
    Article 20 January 2022
  8. Matching-adjusted indirect treatment comparison of chimeric antigen receptor T-cell therapies for third-line or later treatment of relapsed or refractory large B-cell lymphoma: lisocabtagene maraleucel versus tisagenlecleucel

    Background

    There are no head-to-head clinical studies comparing chimeric antigen receptor (CAR) T-cell therapies for the treatment of relapsed or...

    Guillaume Cartron, Christopher P. Fox, ... John Kuruvilla in Experimental Hematology & Oncology
    Article Open access 25 March 2022
  9. De lessen van Cindy en Jason

    Annemarie de Leng in Kind & Adolescent Praktijk
    Article 31 May 2024
  10. WHO-Klassifikation 2022 chronischer myeloproliferativer Erkrankungen

    Background

    Human neoplasms of various organ systems are being hierarchically cataloged by the World Health Organization (WHO) in a unified relational...

    Andreas Hochhaus, German Ott, Reiner Siebert in Die Onkologie
    Article 24 January 2023
  11. The progress of novel strategies on immune-based therapy in relapsed or refractory diffuse large B-cell lymphoma

    Diffuse large B-cell lymphoma (DLBCL) can be cured with standard front-line immunochemotherapy, whereas nearly 30–40% of patients experience...

    Tingxun Lu, Jie Zhang, ... Ken H. Young in Experimental Hematology & Oncology
    Article Open access 14 August 2023
  12. Eosinophilie: hypereosinophiles Syndrom versus eosinophile Granulomatose mit Polyangiitis

    Hypereosinophilic syndrome (HES) is defined as a peripheral eosinophil count of > 1500/μl (assessed twice at an interval of ≥ 2 weeks) and an...

    Julia U. Holle, Frank Moosig in Zeitschrift für Rheumatologie
    Article 26 April 2023
  13. Hematologic malignancies following immune checkpoint inhibition for solid tumors

    Immune checkpoint inhibition (ICI) can induce durable responses in patients with advanced malignancies. Three cases of hematological neoplasia...

    Mick J. M. van Eijs, Lotte E. van der Wagen, ... Karijn P. M. Suijkerbuijk in Cancer Immunology, Immunotherapy
    Article Open access 13 June 2022
  14. Melatonin Language in Postharvest Life of Horticultural Crops

    During postharvest life, fresh horticultural crops suffer from sensory and nutritional quality deterioration accompanied by fungal decay incidence....
    Chapter 2023
  15. Tisagenlecleucel

    Article 08 July 2023
  16. Axicabtagene ciloleucel as first-line therapy in high-risk large B-cell lymphoma: the phase 2 ZUMA-12 trial

    High-risk large B-cell lymphoma (LBCL) has poor outcomes with standard first-line chemoimmunotherapy. In the phase 2, multicenter, single-arm ZUMA-12...

    Sattva S. Neelapu, Michael Dickinson, ... Julio C. Chavez in Nature Medicine
    Article Open access 21 March 2022
  17. Novel CD19-specific γ/δ TCR-T cells in relapsed or refractory diffuse large B-cell lymphoma

    Background

    T cell receptor (TCR)-T cells possess similar effector function, but milder and more durable signal activation compared with chimeric...

    Chenggong Li, Fen Zhou, ... Yu Hu in Journal of Hematology & Oncology
    Article Open access 21 January 2023
  18. Study of the Production of Sodium Hydroxide by Bipolar Electrodialysis from Sodium Carbonate Solution

    Abstract

    In this work, the production of sodium hydroxide by the method of bipolar electrodialysis from a solution of sodium carbonate using bipolar...

    E. N. Nosova, D. M. Musatova, ... V. I. Zabolotsky in Membranes and Membrane Technologies
    Article 01 October 2023
Did you find what you were looking for? Share feedback.